Introduction: Hepatitis C virus (HCV) infection is a major public health challenge. It is a major cause for cirrhosis and hepatocellular carcinoma worldwide. Both the genotype and viral load of HCV determine the choice of therapy as well as outcome of therapy. The aim of this study was to evaluate clinical, biochemical and virological profile and association of HCV genotypes with viral load and liver biochemical profile.
Introduction
Hepatitis C virus (HCV) infection is a major public health challenge worldwide. About 170 million people or 3% of world's population are infected with HCV. 1 More than 350,000 deaths annually are attributed to HCV infection, most of which are caused by cirrhosis of liver and hepatocellular carcinoma (HCC). 2 An estimated 27% of cirrhosis and 25% of HCC can be attributed to HCV worldwide. 2 In developed countries, the most important route of HCV transmission is intra-venous drug use, whereas in resource poor countries, invasive procedures or injection-based therapies with contaminated instruments are predominant source of new infections. 3 Different studies from Nepal showed that the sero-prevalence of HCV ranges from 0.35% to 1.73% in blood donors and healthy population with highest prevalence among injection drug users. [4] [5] [6] [7] [8] Six different HCV genotypes and multiple subtypes have been identified on the basis of molecular relatedness. 
Discussion
This study included 38 patients with chronic HCV infection. Among these patients 89.5% were male and 10.5% were female. Among 38 patients, 34(89.47%) patients had identifiable risk factors for HCV transmission. Injection drug use was most common identifiable risk factor followed by the history of blood transfusion in our study population which was in concordance with the study conducted by Hu KQ from United States. 12 In similar studies from India conducted by R. Abraham and A. Chakravarti also showed the most common identifiable risk factor for HCV acquisition was history of surgery followed by blood transfusion. 13, 14 The mode of transmission was not identifiable in 10.5% of patients in this study population. A study from India showed that risk factors were not indentified in 22.53% of patients.
14 There was no published data on the distribution of different HCV genotypes among HCV infected patients found in Nepal. This study showed genotype 3 (55.26%) as the most common genotype followed by genotype 1 (44.74%). The relationship between serum liver enzyme and degree of liver damage in chronic HCV infection was still not clear in this study but some studies documented. 11, 15 However, in some studies, there were no relation between serum ALT level and severity of liver damage histologically found. 13, 16 A study done by R. Abraham in India had shown that there was no association between HCV genotype and serum aminotransferases. 13 However, another study done by A Chakravarti in India had shown that serum AST level was significantly higher in genotype 1 as compared to other genotype.
14 A similar study done in Turkey by S. Rota had demonstrated that the serum level of ALT and AST in HCV genotype 4 were significantly higher than those infected with other genotypes. 17 In this study, there was no significant association between HCV genotype and the mean level of serum ALT level and serum AST level was found. In a study from India conducted by R. Abraham found that serum ALT level correlated poorly with HCV genotype 13, 14 . There was little information regarding the correlation between the HCV genotype and viral load found. Some studies had shown that there was no relationship between the HCV genotype and HCV viral load. 11, 18 A study conducted at Pakistan in 2011 showed a significant higher HCV viral load in genotype 1 as compared to other genotypes. 19 A similar kind of study done in India also showed that viral load in patients with genotype 1 was significantly higher than other HCV genotypes.
14 In this study, there was no significant association between HCV viral load and HCV genotypes.
Conclusions
In conclusion, this study showed that HCV genotype 3 was the most common genotype followed by genotype 1. Other Genotypes were not found in this study population. This study also revealed that there was no significant relation between the HCV genotypes, serum ALT and serum AST level. Baseline HCV viral load was also not significantly associated with different HCV genotypes.
